Identification and validation of a novel prognostic signature based on mitochondria and oxidative stress related genes for glioblastoma
暂无分享,去创建一个
Yang Xu | Fan-En Yuan | Daofeng Tian | Qian Sun | Yixuan Wang | Liguo Ye | Jiayang Cai | Zhang Ye | Shi’ao Tong | Minqi Xia
[1] Y. Pang,et al. A BAK subdomain that binds mitochondrial lipids selectively and releases cytochrome C , 2022, Cell Death & Differentiation.
[2] Zhuting Tong,et al. Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma , 2022, Frontiers in Oncology.
[3] Jun Zhang,et al. Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer. , 2022, Combinatorial chemistry & high throughput screening.
[4] Teng-yue Zeng,et al. A novel 17 apoptosis-related genes signature could predict overall survival for bladder cancer and its associations with immune infiltration , 2022, Heliyon.
[5] Yue Zhou,et al. Pan-Cancer Analysis Reveals SH3TC2 as an Oncogene for Colorectal Cancer and Promotes Tumorigenesis via the MAPK Pathway , 2022, Cancers.
[6] A. Acharya,et al. Identification of Key Pyroptosis-Related Genes and Distinct Pyroptosis-Related Clusters in Periodontitis , 2022, Frontiers in Immunology.
[7] Yuhong Wang,et al. Breast Cancer Prognosis Prediction and Immune Pathway Molecular Analysis Based on Mitochondria-Related Genes , 2022, Genetics research.
[8] Huachun Yin,et al. Drp1-Mediated Mitochondrial Metabolic Dysfunction Inhibits the Tumor Growth of Pituitary Adenomas , 2022, Oxidative medicine and cellular longevity.
[9] Jihong Liu,et al. A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma , 2021, Oxidative medicine and cellular longevity.
[10] Wen Ai,et al. Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis , 2021, Frontiers in Pharmacology.
[11] Yang Xu,et al. Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas , 2021, Cancer medicine.
[12] Elias S. J. Arnér,et al. Thioredoxin Reductase Inhibition for Cancer Therapy. , 2021, Annual review of pharmacology and toxicology.
[13] S. Murray,et al. Glioblastoma: clinical presentation, diagnosis, and management , 2021, BMJ.
[14] Zhiwei Cao,et al. Rank-in: enabling integrative analysis across microarray and RNA-seq for cancer , 2021, Nucleic acids research.
[15] Bo Wang,et al. Expressions and significances of CTSL, the target of COVID‐19 on GBM , 2021, Journal of Cancer Research and Clinical Oncology.
[16] Kaoxiang Sun,et al. Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study. , 2021, Journal of pharmaceutical sciences.
[17] S. Pauklin,et al. ROS and TGFβ: from pancreatic tumour growth to metastasis , 2021, Journal of experimental & clinical cancer research : CR.
[18] Yu-Wen Lin,et al. Cinnamophilin enhances temozolomide-induced cytotoxicity against malignant glioma: the roles of ROS and cell cycle arrest , 2021, Translational cancer research.
[19] Lei Jin,et al. Downregulation of STOX1 is a novel prognostic biomarker for glioma patients , 2021, Open life sciences.
[20] Apekshya Panda,et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations , 2020, Nucleic Acids Res..
[21] Fusheng Liu,et al. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas , 2020, Cell Death & Disease.
[22] Hao Zhou,et al. Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: New insights into the mechanisms and therapeutic potentials. , 2020, Pharmacological research.
[23] Xinxin Zhang,et al. MTH1 Inhibitor TH287 Suppresses Gastric Cancer Development Through the Regulation of PI3K/AKT Signaling. , 2020, Cancer biotherapy & radiopharmaceuticals.
[24] Joshua A. Bittker,et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling , 2020, Nature Cancer.
[25] Gopika G. Nair,et al. Author Correction: Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells , 2019, Nature Cell Biology.
[26] M. Pesee,et al. Survival Analysis of Glioblastoma Multiforme , 2018, Asian Pacific journal of cancer prevention : APJCP.
[27] G. Song,et al. Chrysin disrupts intracellular homeostasis through mitochondria-mediated cell death in human choriocarcinoma cells. , 2018, Biochemical and biophysical research communications.
[28] J. Prudent,et al. Mitochondrial dynamics: overview of molecular mechanisms , 2018, Essays in biochemistry.
[29] N. Neamati,et al. Current Challenges and Opportunities in Treating Glioblastoma , 2018, Pharmacological Reviews.
[30] A. Ferreira,et al. The Roles of ROS in Cancer Heterogeneity and Therapy , 2017, Oxidative medicine and cellular longevity.
[31] Tao Jiang,et al. Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas , 2017, Scientific Data.
[32] Dima Suki,et al. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. , 2016, JAMA oncology.
[33] Mark D. Johnson,et al. Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis. , 2016, American journal of translational research.
[34] Hsin-Chen Lee,et al. Role of mitochondrial dysfunction in cancer progression , 2016, Experimental biology and medicine.
[35] Lin Shi,et al. Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[36] X. Qu,et al. Cancer biomarker detection: recent achievements and challenges. , 2015, Chemical Society reviews.
[37] V. Víctor,et al. Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. , 2015, Antioxidants & redox signaling.
[38] T. Qian,et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. , 2015, Neuro-oncology.
[39] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[40] J. Kirkpatrick,et al. Recurrent malignant gliomas. , 2014, Seminars in radiation oncology.
[41] B. Rosen,et al. Advanced magnetic resonance imaging of the physical processes in human glioblastoma. , 2014, Cancer research.
[42] M. Ricchetti,et al. Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated gene. , 2014, Antioxidants & redox signaling.
[43] J. Nunnari,et al. Mitochondrial form and function , 2014, Nature.
[44] K. Aldape,et al. Using the molecular classification of glioblastoma to inform personalized treatment , 2014, The Journal of pathology.
[45] Hongchuan Jin,et al. Regulation and function of mitophagy in development and cancer , 2013, Autophagy.
[46] Mark W. Dewhirst,et al. ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells , 2012, Breast Cancer Research and Treatment.
[47] Tsviya Olender,et al. GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.
[48] J. Haorah,et al. Mechanism of alcohol-induced oxidative stress and neuronal injury. , 2008, Free radical biology & medicine.
[49] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[50] K. Tanabe,et al. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity , 2006, Immunology.
[51] Y. Nakabeppu,et al. MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides. , 2006, DNA repair.
[52] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[53] Hoshing Chang,et al. Involvements of mitochondrial thioredoxin reductase (TrxR2) in cell proliferation. , 2003, Biochemical and biophysical research communications.
[54] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..